Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Hoda MA, Dong Y, Rozsas A, Klikovits T, Laszlo V, Ghanim B, Stockhammer P, Ozsvar J, Jakopovic M, Samarzija M, Brcic L, Bendek M, Szirtes I, Reid G, Kirschner MB, Kao SC, Opitz I, Weder W, Frauenfelder T, Nguyen-Kim TD, Aigner C, Klepetko W, van Zandwijk N, Berger W, Dome B, Grusch M, Hegedus B. Hoda MA, et al. Among authors: grusch m. Eur J Cancer. 2016 Aug;63:64-73. doi: 10.1016/j.ejca.2016.04.018. Epub 2016 Jun 8. Eur J Cancer. 2016. PMID: 27288871
Deregulation of the activin/follistatin system in hepatocarcinogenesis.
Grusch M, Drucker C, Peter-Vörösmarty B, Erlach N, Lackner A, Losert A, Macheiner D, Schneider WJ, Hermann M, Groome NP, Parzefall W, Berger W, Grasl-Kraupp B, Schulte-Hermann R. Grusch M, et al. J Hepatol. 2006 Nov;45(5):673-80. doi: 10.1016/j.jhep.2006.06.014. Epub 2006 Jul 28. J Hepatol. 2006. PMID: 16935389
The activin axis in liver biology and disease.
Rodgarkia-Dara C, Vejda S, Erlach N, Losert A, Bursch W, Berger W, Schulte-Hermann R, Grusch M. Rodgarkia-Dara C, et al. Among authors: grusch m. Mutat Res. 2006 Nov-Dec;613(2-3):123-37. doi: 10.1016/j.mrrev.2006.07.002. Epub 2006 Sep 25. Mutat Res. 2006. PMID: 16997617 Review.
FGF18 in colorectal tumour cells: autocrine and paracrine effects.
Sonvilla G, Allerstorfer S, Stättner S, Karner J, Klimpfinger M, Fischer H, Grasl-Kraupp B, Holzmann K, Berger W, Wrba F, Marian B, Grusch M. Sonvilla G, et al. Among authors: grusch m. Carcinogenesis. 2008 Jan;29(1):15-24. doi: 10.1093/carcin/bgm202. Epub 2007 Sep 22. Carcinogenesis. 2008. PMID: 17890768
Activins and activin antagonists in hepatocellular carcinoma.
Deli A, Kreidl E, Santifaller S, Trotter B, Seir K, Berger W, Schulte-Hermann R, Rodgarkia-Dara C, Grusch M. Deli A, et al. Among authors: grusch m. World J Gastroenterol. 2008 Mar 21;14(11):1699-709. doi: 10.3748/wjg.14.1699. World J Gastroenterol. 2008. PMID: 18350601 Free PMC article. Review.
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
Fischer H, Taylor N, Allerstorfer S, Grusch M, Sonvilla G, Holzmann K, Setinek U, Elbling L, Cantonati H, Grasl-Kraupp B, Gauglhofer C, Marian B, Micksche M, Berger W. Fischer H, et al. Among authors: grusch m. Mol Cancer Ther. 2008 Oct;7(10):3408-19. doi: 10.1158/1535-7163.MCT-08-0444. Mol Cancer Ther. 2008. PMID: 18852144 Free PMC article.
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.
Sonvilla G, Allerstorfer S, Heinzle C, Stättner S, Karner J, Klimpfinger M, Wrba F, Fischer H, Gauglhofer C, Spiegl-Kreinecker S, Grasl-Kraupp B, Holzmann K, Grusch M, Berger W, Marian B. Sonvilla G, et al. Among authors: grusch m. Br J Cancer. 2010 Mar 30;102(7):1145-56. doi: 10.1038/sj.bjc.6605596. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234367 Free PMC article.
179 results